MicroRNA expression aberration associated with bronchopulmonary dysplasia in preterm infants: A preliminary study

Respiratory Care

Volumn 58, Issue 9, 2013, Pages 1527-1535

  Wu, Yen Tzu ^a   Chen, Wei J ^b   Hsieh, Wu Shiun ^a   Tsao, Po Nien ^a   Yu, Sung Liang ^a   Lai, Chi Yu ^b   Lee, Wen Chung ^b   Jeng, Suh Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Biomarkers; Bronchopulmonary dysplasia; Expression profiling; MicroRNA; Peripheral blood

Indexed keywords

MICRORNA; MICRORNA 133B; MICRORNA 152; MICRORNA 30A; MICRORNA 7; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC DISORDER; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MALE; PATHOGENESIS; PERINATAL PERIOD; PREMATURITY; PROSPECTIVE STUDY; RNA ANALYSIS; UPREGULATION; VALIDATION PROCESS; VERY LOW BIRTH WEIGHT;

BIOMARKERS; BRONCHOPULMONARY DYSPLASIA; EXPRESSION PROFILING; MICRORNA; PERIPHERAL BLOOD;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LOGISTIC MODELS; MALE; MICRORNAS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; UP-REGULATION;

EID: 84883295954     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02166     Document Type: Article

References (54)

1. Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006;117(3 Pt 2):S52-S56.
2. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196(2):147.e141-e148.
3. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163(7):1723-1729.
4. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006;367(9520):1421-1431.
5. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007;357(19):1946-1955.
6. Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009;123(6):1562-1573.
7. Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006;117(6):1901-1906.
8. Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008;122(3):479-485.
9. Kazzi SN, Kim UO, Quasney MW, Buhimschi I. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004; 114(2):e243-e248.
10. Yanamandra K, Boggs P, Loggins J, Baier RJ. Interleukin-10-1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. Pediatr Pulmonol 2005; 39(5):426-432.
11. Balogh A, Treszl A, Vannay A, Vasarhelyi B. A prevalent functional polymorphism of insulin-like growth factor system is not associated with perinatal complications in preterm infants. Pediatrics 2006; 117(2):591-592.
12. Lin HC, Su BH, Hsu CM, Chou IC, Wu KH, Lin HC, et al. No association between TAP1 DpnII polymorphism and bronchopulmonary dysplasia. Acta Paediatr Taiwan 2005;46(6):341-345.
13. Adcock K, Hedberg C, Loggins J, Kruger TE, Baier RJ. The TNF-alpha -308, MCP-1-2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun 2003;4(6):420-426.
14. Strassberg SS, Cristea IA, Qian D, Parton LA. Single nucleotide polymorphisms of tumor necrosis factor-alpha and the susceptibility to bronchopulmonary dysplasia. Pediatr Pulmonol 2007;42(1):29-36.
15. Derzbach L, Bokodi G, Treszl A, Vásárhelyi B, Nobilis A, Rigó JJ. Selectin polymorphisms and perinatal morbidity in low-birthweight infants. Acta Paediatr 2006;95(10):1213-1217.
16. Weber B, Borkhardt A, Stoll-Becker S, Reiss I, Gortner L. Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants. Turk J Pediatr 2000;42(3): 181-185.
17. Pavlovic J, Papagaroufalis C, Xanthou M, Liu W, Fan R, Thomas NJ, et al. Genetic variants of surfactant proteins A, B, C, and D, in bronchopulmonary dysplasia. Dis Markers 2006;22(5-6):277-291.
18. Bry K, Whitsett JA, Lappalainen U. IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol 2007;36(1): 32-42.
19. Altiok O, Yasumatsu R, Bingol-Karakoc G, Riese RJ, Stahlman MT, Dwyer W, et al. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2006;173(3):318-326.
20. Bland RD, Xu L, Ertsey R, Rabinovitch M, Albertine KH, Wynn KA, et al. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2007;292(6):L1370-L1384.
21. Tambunting F, Beharry KD, Hartleroad J, Waltzman J, Stavitsky Y, Modanlou HD. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia. Pediatr Pulmonol 2005;39(1):5-14.
22. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 2002;282(4):L811-L823.
23. Zhang C. MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics 2008;33(2):139-147.
24. Homo sapiens miRNAs (1872 sequences). miRBase: the microRNA database. http://www.mirbase.org/cgi-bin/mirna_summary.pl?org=hsa. Accessed June 26, 2013.
25. Bentwich I. Prediction and validation of microRNAs and their targets. FEBS Lett 2005;579(26):5904-5910.
26. Friedman JM, Jones PA. MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly 2009;139 (33-34):466-472.
27. Williams AE, Moschos SA, Perry MM, Barnes PJ, Lindsay MA. Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev Dyn 2007;236(2):572-580.
28. Bhaskaran M, Wang Y, Zhang H, Weng T, Baviskar P, Guo Y, et al. MicroRNA-127 modulates fetal lung development. Physiol Genomics 2009;37(3):268-278.
29. Wang Y, Weng T, Gou D, Chen Z, Chintagari NR, Liu L. Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research. BMC Genomics 2007;8:29.
30. Lu Y, Okubo T, Rawlins E, Hogan BL. Epithelial progenitor cells of the embryonic lung and the role of microRNAs in their proliferation. Proc Am Thorac Soc 2008;15(3):300-304.
31. Zhang X, Peng W, Zhang S, Wang C, He X, Zhang Z, et al. MicroRNA expression profile in hyperoxia-exposed newborn mice during the development of bronchopulmonary dysplasia. Respir Care 2011; 56(7):1009-1015.
32. Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS, et al. Real-time PCR quantification of precursor and mature microRNA. Methods 2008;44(1):31-38.
33. Lai CY, Yu SL, Hsieh MH, Chen CH, Chen HY, Wen CC, et al. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One 2011;6(6):e21635.
34. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk-Database: prediction of possible miRNA binding sites by "walking" the genes of 3 genomes. J Biomed Inform 2011;44(5):839-847.
35. Wu H, M,. A graphical environment for matrix visualization and cluster analysis. Comput Stat Data Anal 2010;54(3):767-778.
36. Hsu SD, Chu CH, Tsou AP, Chen SJ, Chen HC, Hsu PW, et al. miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes. Nucleic Acids Res 2008;36(Database issue):D165-D169.
37. Gao W, Shen H, Liu L, Xu J, Shu Y. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 2010;137(4):557-566.
38. Crawford M, Batte K, Yu L, Wu X, Nuovo GJ, Marsh CB, et al. MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem Biophys Res Commun 2009;388(3):483-489.
39. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 2009;4(11): e8003.
40. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007;81(4):829-834.
41. Guimbellot JS, Erickson SW, Mehta T, Wen H, Page GP, Sorscher EJ, et al. Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis. BMC Med Genomics 2009;25:2-15.
42. Caruso P, MacLean MR, Khanin R, McClure J, Soon E, Southgate M, et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 2010;30(4):716-723.
43. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia Am J Respir Crit Care Med 2001; 164(10 Pt 1):1971-1980.
44. Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006;30(4):179-184.
45. Thébaud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 2007;175(10):978-985.
46. Comai G, Boutet A, Neirijnck Y, Schedl A. Expression patterns of the Wtx/Amer gene family during mouse embryonic development. Dev Dyn 2010;239(6):1867-1878.
47. Grunder A, Ebel TT, Mallo M, Schwarzkopf G, Shimizu T, Sippel AE, et al. Nuclear factor I-B (Nfib) deficient mice have severe lung hypoplasia. Mech Dev 2002;112(1-2):69-77.
48. Li Y, Zhang H, Choi SC, Litingtung Y, Chiang C. Sonic hedgehog signaling regulates Gli3 processing, mesenchymal proliferation, and differentiation during mouse lung organogenesis. Dev Biol 2004; 270(1):214-231.
49. Zhang M, Wang H, Teng H, Shi J, Zhang Y. Expression of SHH signaling pathway components in the developing human lung. Histochem Cell Biol 2010;134(4):327-335.
50. Steele-Perkins G, Plachez C, Butz KG, Yang G, Bachurski CJ, Kinsman SL, et al. The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol Cell Biol 2005; 25(2):685-698.
51. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 2009;37:D105-D110.
52. Pongracz JE, Stockley RA. Wnt signalling in lung development and diseases. Respir Res 2006;26:7-15.
53. Cohen ED, Ihida-Stansbury K, Lu MM, Panettieri RA, Jones PL, Morrisey EE. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. J Clin Invest 2009;119(9):2538-2549.
54. Chen F, Cao Y, Qian J, Shao F, Niederreither K, Cardoso WV. A retinoic acid-dependent network in the foregut controls formation of the mouse lung primordium. J Clin Invest 2010;120(6):2040-2048.